Insider Transactions in Q2 2023 at Cvs Health Corp (CVS)
Insider Transaction List (Q2 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 18
2023
|
Fernando Aguirre Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,329
+4.22%
|
$91,701
$69.31 P/Share
|
|
May 18
2023
|
Jeffrey R. Balser Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,329
+28.86%
|
$91,701
$69.31 P/Share
|
|
May 18
2023
|
Nancy Ann Deparle Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,437
+4.95%
|
$99,153
$69.31 P/Share
|
|
May 18
2023
|
Anne A. Finucane Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,437
+14.1%
|
$99,153
$69.31 P/Share
|
|
May 18
2023
|
Jean Pierre Millon Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,437
+50.0%
|
$99,153
$69.31 P/Share
|
|
May 03
2023
|
Karen S Lynch President and CEO |
BUY
Open market or private purchase
|
Direct |
14,000
+3.14%
|
$966,000
$69.75 P/Share
|
|
Apr 01
2023
|
Michelle A Peluso EVP and Co-President of Retail |
SELL
Payment of exercise price or tax liability
|
Direct |
98,299
-44.14%
|
$7,274,126
$74.31 P/Share
|
|
Apr 01
2023
|
Prem S Shah EVP and Pres-Pharm, Consumer W |
SELL
Payment of exercise price or tax liability
|
Direct |
3,221
-6.13%
|
$238,354
$74.31 P/Share
|
|
Apr 01
2023
|
Karen S Lynch President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
93,677
-45.34%
|
$6,932,098
$74.31 P/Share
|
|
Apr 01
2023
|
Sreekanth K Chaguturu EVP and Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,854
-22.39%
|
$137,196
$74.31 P/Share
|
|
Apr 01
2023
|
James David Clark SVP, Cont & Chief Acct Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,186
+19.4%
|
$161,764
$74.31 P/Share
|
|
Apr 01
2023
|
James David Clark SVP, Cont & Chief Acct Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,471
-4.61%
|
$108,854
$74.31 P/Share
|
|
Apr 01
2023
|
Daniel P Finke EVP/Pres, Health Care Benefits |
SELL
Payment of exercise price or tax liability
|
Direct |
3,856
-9.91%
|
$285,344
$74.31 P/Share
|